Catamount Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-7,710
| Closed | -$1.47M | – | 218 |
|
|
2018
Q4 | $1.47M | Sell |
7,710
-1,995
| -21% | -$381K | 1% | 18 |
|
|
2018
Q3 | $1.87M | Sell |
9,705
-60
| -0.6% | -$11.6K | 0.9% | 22 |
|
|
2018
Q2 | $1.71M | Buy |
9,765
+2,635
| +37% | +$461K | 0.83% | 23 |
|
|
2018
Q1 | $1.16M | Buy |
7,130
+1,475
| +26% | +$240K | 0.62% | 26 |
|
|
2017
Q4 | $847K | Sell |
5,655
-9,270
| -62% | -$1.39M | 0.47% | 26 |
|
|
2017
Q3 | $2.27M | Buy |
+14,925
| New | +$2.27M | 1.32% | 22 |
|